FS Development Corp II Cl A (FSII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FSII | IMUX | ANIK | ||
| Company | FS Development Corp II Cl A | Immunic Inc | Anika Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.05 | 15.10 | 15.22 | ||
| High | 10.16 | 15.11 | 15.49 | ||
| Low | 9.69 | 14.27 | 14.79 | ||
| Latest | 9.80 | 15.10 | 15.01 | ||
| Change | -0.20 | -0.05 | -0.15 | ||
| % Change | -2.00% | -0.33% | -0.99% | ||
| Volume | 289,100 | 191,325 | 57,199 | ||
| 20-Day Average Volume | 227,795 | 170,826 | 72,240 | ||
| Previous Close | 10.00 | 15.15 | 15.16 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 11.86 | 14.99 | 15.40 | ||
| 20-Day Raw Stochastic | 2.99% | 56.73% | 31.95% | ||
| 20-Day Relative Strength | 38.90 | 57.47 | 48.87 | ||
| Weighted Alpha | -13.88 | +34.55 | +31.81 | ||
| Today's Opinion | 8% Buy | 100% Buy | 88% Buy | ||
| Previous Opinion | 8% Buy | 100% Buy | 88% Buy | ||
| Last Month's Opinion | 72% Buy | 100% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.89% since 12/16/21 | unch since 07/15/26 | -5.78% since 07/15/26 | ||
| Low | 9.64 on 12/21/21 | 14.27 on 07/22/26 | 14.79 on 07/22/26 | ||
| High | 10.86 on 12/21/21 | 15.84 on 07/17/26 | 16.20 on 07/16/26 | ||
| 1-Month | |||||
| %Chg | -30.10% since 11/23/21 | +2.37% since 06/22/26 | +5.70% since 06/22/26 | ||
| Low | 9.64 on 12/21/21 | 14.12 on 06/23/26 | 14.13 on 06/23/26 | ||
| High | 15.00 on 12/01/21 | 15.84 on 07/17/26 | 16.49 on 07/07/26 | ||
| 3-Month | |||||
| %Chg | -1.90% since 09/23/21 | +67.78% since 04/22/26 | -3.47% since 04/22/26 | ||
| Low | 9.64 on 12/21/21 | 8.50 on 04/27/26 | 11.92 on 04/30/26 | ||
| High | 15.05 on 11/19/21 | 15.84 on 07/17/26 | 16.49 on 07/07/26 | ||
| 6-Month | |||||
| %Chg | -0.81% since 06/23/21 | +119.35% since 01/22/26 | +59.85% since 01/22/26 | ||
| Low | 9.64 on 12/21/21 | 5.73 on 02/05/26 | 9.01 on 01/28/26 | ||
| High | 15.05 on 11/19/21 | 15.84 on 07/17/26 | 16.49 on 07/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 203,125 | 206,358 | 201,719 | ||
| Shares Outstanding, K | 20,727 | 13,621 | 13,306 | ||
| Annual Sales | 0 | 0 | 112,820,000 | ||
| Annual Net Income | 0 | -97,170,000 | -10,880,000 | ||
| Last Quarter Sales | 0 | 0 | 29,610,000 | ||
| Last Quarter Net Income | -1,220,000 | -32,590,000 | -5,060,000 | ||
| 60-Month Beta | N/A | 1.37 | 0.23 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/12/21 | -1.08 on 05/13/26 | 0.27 on 04/29/26 | ||
| Earnings Date | 01/01/70 | 08/06/26 | 07/29/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||